Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells by Anna R. Bopp, Felipe F. Lamenza, Puja Upadhaya, Nathan M. Ryan, Natalie Kazmierowicz, Pete P. Jordanides, Arham Siddiqui, Sherefuddin H. Pracha, Peyton Roth, O. Hans Iwenofu, Steve Oghumu

Get full text